Cytokinetics
CYTK | NASDAQ
$67.89
-$0.89 (-1.29%)
Sep 21, 2026, 11:13 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 88.04M | 18.47M | 7.53M | 94.59M | 70.43M | 55.83M |
Cost of Revenue | 10.13M | 339.41M | 330.12M | 240.81M | 159.94M | 96.95M |
Gross Profit | 77.91M | -320.93M | -322.59M | -146.23M | -89.51M | -41.12M |
Operating Income | -612.26M | -536.25M | -496.21M | -324.2M | -186.31M | -93.94M |
Interest Income | 48.42M | 51.53M | 27.63M | 11.34M | 331K | 5.33M |
Pretax Income | -784.96M | -589.53M | -526.24M | -388.96M | -215.31M | -127.29M |
Net Income | -784.96M | -589.53M | -526.24M | -388.96M | -215.31M | -127.29M |
Selling & General & Admin | 284.27M | 215.31M | 173.61M | 177.98M | 96.8M | 52.82M |
Research & Development | 405.9M | 339.41M | 330.12M | 240.81M | 159.94M | 96.95M |
Other Expenses | n/a | -339.41M | -330.12M | -240.81M | -159.94M | -96.95M |
Operating Expenses | 690.17M | 215.31M | 173.61M | 177.98M | 96.8M | 52.82M |
Interest Expense | 103.87M | 86.51M | 57.67M | 51.16M | 29.33M | 38.68M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 700.3M | 554.72M | 503.74M | 418.79M | 256.74M | 149.77M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 120.02M | 111.98M | 96.52M | 89.83M | 76.89M | 64.52M |
Shares Outstanding (Diluted) | 120.1M | 111.98M | 96.52M | 89.83M | 76.89M | 64.52M |
EPS (Basic) | -6.54 | -5.26 | -5.45 | -4.33 | -2.80 | -1.97 |
EPS (Diluted) | -6.54 | -5.26 | -5.45 | -4.33 | -2.80 | -1.97 |
EBITDA | -775.27M | -493.48M | -456.68M | -329.4M | -176.35M | -86.78M |
EBIT | -784.96M | -503.01M | -468.58M | -337.8M | -185.98M | -88.61M |
Depreciation & Amortization | 9.69M | 9.53M | 11.89M | 8.4M | 9.64M | 1.83M |
Add to Watchlist
Select watchlists to add or remove CYTK